Bryan Durkin compensation by year
CME Summary Compensation Table · all 4 fiscal years held| Component | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Salary | $700,000 | $800,000 | $900,000 | $900,000 |
| Bonus | $0 | $0 | $0 | $0 |
| Stock awards | $2,319,131 | $2,726,645 | $3,504,344 | $2,977,009 |
| Option awards | $0 | $0 | $0 | $0 |
| Non-equity incentive | $904,056 | $1,317,781 | $1,963,757 | $1,375,101 |
| Pension and deferred compensation | $96,904 | $97,322 | $0 | $186,480 |
| All other | $162,834 | $151,323 | $220,282 | $257,650 |
| Total | $4,182,925 | $5,093,071 | $6,588,383 | $5,696,240 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CME GROUP INC. DEF 14A filed March 18, 2020, accession 0001193125-20-076774, and prior-year filings. Open the filing on EDGAR.
How this page was built: the CME GROUP INC. filed document, accession 0001193125-20-076774. Every figure is read from that document and cited to the page and table it appears in. Filed March 18, 2020.
Equity holdings
unvested awards at FY2019 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 19,216 | $3,857,036 | — |
| RSU | 6,520 | $1,308,694 | — |
| RSU | 5,847 | $1,173,610 | — |
| PSU | 4,570 | $917,290 | — |
| RSU | 4,570 | $917,290 | — |
| PSU | 3,899 | $782,607 | — |
| PSU | 3,261 | $654,548 | — |
| RSU | 2,402 | $482,129 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in CME GROUP INC.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
13 Form 4 lines since the FY2019 proxy (filed March 18, 2020)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-06-25 | Grant or award | — | 645 | $225.00 | 43,652 |
| 2026-02-23 | Sale | — | 4,200 | $309.65 | 43,007 |
| 2025-06-25 | Grant or award | — | 532 | $273.03 | 47,207 |
| 2024-09-03 | Gift | — | 465 | $0.00 | 55,142 |
| 2024-08-30 | Sale | — | 7,593 | $214.59 | 55,607 |
| 2024-06-25 | Grant or award | — | 748 | $194.10 | 63,200 |
| 2023-12-11 | Sale | — | 5,560 | $216.37 | 62,452 |
| 2023-06-26 | Grant or award | — | 811 | $178.89 | 68,012 |
The 8 most recent of 13 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
CME’s named executive officers, FY2019
as the company reported each| Named executive officer | Role | FY2019 total |
|---|---|---|
| Terrence Duffy | Chairman and Chief Executive Officer | $11,867,214 |
| Bryan Durkin · this page | President | $5,696,240 |
| John Pietrowicz | Chief Financial Officer | $3,300,001 |
| Julie Holzrichter | Chief Operating Officer | $2,999,330 |
| Kevin Kometer | Chief Information Officer | $2,817,636 |
Board service
CME board · FY2021–FY2025| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $124,000 | $145,252 | — | $0 | $269,252 |
| FY2024 | $121,500 | $145,187 | — | $0 | $266,687 |
| FY2023 | $114,000 | $145,080 | — | $0 | $259,080 |
| FY2022 | $107,000 | $155,566 | — | $0 | $262,566 |
| FY2021 | $23,000 | $80,110 | — | $94,087 | $198,856 |
Each year as the company reported it in CME's director compensation table. Totals are the company's own disclosed totals.
How this board is paid
Company policy: CME pays directors a $95,000 cash retainer and $145,000 in Stock (unrestricted shares). As stated in CME's FY2025 proxy.
The full CME compensation record
free company briefThis page is one person within CME's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the CME proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CME's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.